More Than the Epidemiology of Alzheimer's Disease: Contributions of the Canadian Study of Health and Aging

Canadian Journal of Psychiatry

Volumn 49, Issue 2, 2004, Pages 83-91

  Lindsay, Joan ^a,b   Sykes, Elizabeth ^a   McDowell, Ian ^a   Verreault, René ^c   Laurin, Danielle ^c,d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b HEALTH CANADA   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

Author keywords

Alzheimer's disease; Caregiving; Clinical diagnosis; Dementia; Epidemiology; Incidence; Neuropsychological test norms; Prevalence; Risk factors

Indexed keywords

AGE; AGED; AGING; ALZHEIMER DISEASE; CANADA; CAREGIVER; CLINICAL EXAMINATION; COGNITIVE DEFECT; COMMUNITY; CONTROLLED STUDY; DEMENTIA; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; GERIATRIC CARE; GERONTOPSYCHIATRY; HEALTH CARE COST; HEALTH CENTER; HEALTH STATUS; HUMAN; INCIDENCE; INSTITUTIONALIZATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGY; PHYSICAL ACTIVITY; PREDICTION; PREVALENCE; REVIEW; RISK FACTOR; SCIENCE; SCREENING TEST; URINE INCONTINENCE;

EID: 1642389166     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370404900202     Document Type: Review

References (76)

1. Canadian Study of Health and Aging Working Group. Canadian Study of Health and Aging: study methods and prevalence of dementia. CMAJ 1994;150:899-913.
2. Fillenbaum GG. Multidimensional functional assessment of older adults: the Duke Older Americans Resources and Services procedures. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988.
3. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatr 1987;48:314-8.
4. Hébert R, Bravo G, Girouard D. Validation de l'adaptation française du modified mini-mental state (3MS). Rev Gériatrie 1992;17:443-50.
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders-revised. 3rd ed. Washington (DC): American Psychiatric Association; 1987.
6. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
7. Canadian Study of Health and Aging Working Group. The incidence of dementia in Canada. Neurology 2000;55:66-73.
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
9. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, and others. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
10. McLeod DA, Arnott B, Gaudreault N, Boudreau S, Sévigny P. A comparison of two methods for routine, accurate determination of apolipoprotein E genotypes. Alzheimer's Reports 1998;1:211-5.
11. Laurin D, Verreault R, Lindsay J, Dewailly É, Holub BJ. Omega-3 fatty acids and risk of cognitive impairment and dementia. Journal of Alzheimer's Disease 2003;5:315-22.
12. Canadian Study of Health and Aging. The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada. Neurology 1994;44:2073-80.
13. Lindsay J, Hébert R, Rockwood K. The Canadian Study of Health and Aging: risk factors for vascular dementia. Stroke 1997;28:526-30.
14. Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, and others. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002;156:445-53.
15. Hébert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois M-F. Vascular dementia: incidence and risk factors in the Canadian Study of Health and Aging. Stroke 2000;31:1487-93.
16. McDowell I. Alzheimer's disease: insights from epidemiology. Aging Clin Exp Res 2001;13:143-62.
17. Tuokko H, Frerichs RJ, Kristjansson B. Cognitive impairment, no dememtia: concepts and issues. Int Psychogeriatr 2001;13:183-202.
18. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, and others. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997;349:1793-6.
19. Fisk JD, Merry HR, Rockwood K. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology 2003;61:1179-84.
20. Rockwood K, Stolee P, McDowell I. Factors associated with institutionalization of older people in Canada: testing a multifactorial definition of frailty. J Am Geriatr Soc 1996;44:578-82.
21. Gutman GM, Stark A, Donald A, Beattie BL. Contribution of self-reported health ratings to predicting frailty, institutionalization, and death over a 5-year period. Int Psychogeriatr 2001;13:223-31.
22. St John PD, Montgomery PR, Kristjansson B, McDowell I. Cognitive scores, even within the normal range, predict death and institutionalization. Age Ageing 2002;31:373-8.
23. Tuokko H, MacCourt P, Heath Y. Home alone with dementia. Aging Ment Health 1999;3:21-7.
24. Ebly EM, Hogan DB, Rockwood K. Living alone with dementia. Dement Geriatr Cogn Disord 1999;10:541-8.
25. Hill GB, Forbes WF, Lindsay J, McDowell I, Østbye T. Mortality and cognitive status among elderly Canadians living in the community and in institutions: the Canadian Study of Health and Aging. Can J Public Health 1997;88:303-4.
26. Østbye T, Hill G, Steenhuis R. Mortality in elderly Canadians with and without dementia: a 5-year follow-up. Neurology 1999;53:521-6.
27. Østbye T, Steenhuis R, Wolfson C, Walton R, Hill G. Predictors of five-year mortality in older Canadians: the Canadian Study of Health and Aging. J Am Geriatr Soc 1999;47:1249-54.
28. Wolfson C, Wolfson DB, Asgharian M, M'Lan CE, Ostbye T, Rockwood K, and others. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 2001;344:1111-6.
29. Canadian Study of Health and Aging. Patterns of caring for people with dementia in Canada. Can J Aging 1994;13:470-87.
30. Canadian Study of Health and Aging. Patterns and health effects of caring for people with dementia: the impact of changing cognitive residential status. Gerontologist 2002;42:643-52.
31. Durand PJ, Krueger PD, Chambers LW, Grek A, Charles C. Predictors of caregivers' dissatisfaction with community long-term care services for seniors: results from the Canadian Study of Health and Aging. Can J Public Health 1995;86:325-32.
32. Penning MJ. Cognitive impairment, caregiver burden, and the utilization of home health services. J Aging Health 1995;7:233-53.
33. Cohen CA, Colantonio A, Vernich L. Positive aspects of caregiving: rounding out the caregiver experience. Int J Geriatr Psychiatr 2002;17:184-8.
34. Cotantonio A, Kositsky AJ, Cohen C, Vernich L. What support do caregivers of elderly want? Results from the Canadian Study of Health and Aging. Can J Public Health 2001;92:376-9.
35. O'Rourke N, Tuokko H. The psychological and physical costs of caregiving: the Canadian Study of Health and Aging. J Appl Gerontol 2000;19:389-404.
36. Østbye T, Crosse E. Net economic costs of dementia in Canada. CMAJ 1994;151:1457-64.
37. Dalziel WB. Dementia: no longer the silent epidemic. CMAJ 1994;151:1407-9.
38. Hux MJ, O'Brien BJ, Iskedjian M, Goeree R, Gagnon M, Gauthier S. Relation between severity of Alzheimer's disease and costs of caring. CMAJ 1998;159:457-65.
39. Rockwood K, Brown M, Merry H, Sketris I, Fisk J. Societal costs of vascular cognitive impairment in older adults. Stroke 2002;33:1605-9.
40. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 2001;58:498-504.
41. Verreault R, Laurin D, Lindsay J, DeSerres G. Past exposure to vaccines and subsequent risk of Alzheimer's disease. CMAJ 2001;165:1495-8.
42. McDowell I, Kristjansson B, Hill G, Hébert R. Community screening for dementia: the Mini-Mental State Exam (MMSE) and Modified Mini-Mental State Exam (3MS) compared. J Clin Epidemiol 1997;50:377-83.
43. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State:" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
44. Tombaugh TN, McDowell I, Kristjansson B, Hubley AM. Mini-Mental State Examination (MMSE) and the Modified MMSE (3MS): a psychometric comparison and normative data. Psychol Assess 1996;8:48-59.
45. Bravo G, Hébert R. Reliability of the modified mini-mental state examination in the context of a two-phase community prevalence study. Neuroepidemiol 1997;16:141-8.
46. Rockwood K, Tripp DA, Stadnyk K, Fisk J. Screening for cognitive impairment in the elderly: impact of physical function measures added to cognitive screening instruments. Aging Cogn 1994;1:261-70.
47. Tuokko H, Frerichs R, Graham J, Rockwood K, Kristjansson B, Fisk J, and others. Five-year follow-up of cognitive impairment with no dementia. Arch Neurol 2003;60:577-82.
48. Rockwood K, Ebly E, Hachinski V, Hogan D. Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Arch Neurol 1997;54:33-9.
49. Graham JE, Rockwood K, Beattie BL, McDowell I, Eastwood R, Gauthier S. Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging. Neuroepidemiol 1996;15:246-56.
50. Macknight C, Graham J, Rockwood K. Factors associated with inconsistent diagnosis of dementia between physicians and neuropsychologists. J Am Geriatr Soc 1999;47:1294-9.
51. Hogan DB, Ebly EM. Predicting who will develop dementia in a cohort of Canadian seniors. Can J Neurol Sci 2000;27:18-24.
52. St John P, Montgomery P. Are cognitively intact seniors with subjective memory loss more likely to develop dementia? Int J Geriatr Psychiatr 2002;17:814-20.
53. Tuokko H, Woodward TS. Development and validation of a demographic correction system for neuropsychological measures used in the Canadian Study of Health and Aging. J Clin Exp Neuropsychol 1996;18:479-616.
54. O'Connell ME, Tuokko H. The 12-item Buschke memory test: appropriate for use across levels of impairment. Appl Neuropsychol 2002;9:226-33.
55. Tuokko H, Hadjistavropoulos T, Rae S, O'Rourke N. A comparison of alternative approaches to the scoring of clock drawing. Arch Clin Neuropsychol 2000;15:137-48.
56. Crossley M, D'Arcy C, Rawson SB. Letter and category fluency in community-dwelling Canadian seniors: a comparison of normal participants to those with dementia of the Alzheimer or vascular type. J Clin Exp Neuropsychol 1997;19:52-62.
57. O'Rourke N, Tuokko H, Hayden S, Beattie BL. Early identification of dementia: predictive validity of the Clock Test. Arch Clin Neuropsychot 1997;12:257-67.
58. Steenhuis RE, Ostbye T. Neuropsychological test performance of specific diagnostic groups in the Canadian Study of Health and Aging (CSHA). J Clin Exp Neuropsychol 1995;17:773-85.
59. Hogan DB, Ebly EM, Fung TS. Regional variations in use of potentially inappropriate medications by Canadian seniors participating in the Canadian Study of Health and Aging. Can J Clin Pharmacol 1995;2:167-74.
60. Hogan DB, Maxwell CJ, Fung TS, Ebly EM. Regional variation in the use of medications by older Canadians-persistent and incompletely understood phenomena. Pharmacoepidemiol Drug Saf 2003;12:575-82.
61. Rockwood K, Kirkland S, Hogan DB, Macknight C, Merry H, Verreault R, and others. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 2002;59:223-7.
62. Ebly EM, Hogan DB, Fung TS. Potential adverse outcomes of psychotropic and narcotic drug use in Canadian seniors. J Clin Epidemiol 1997;50:857-63.
63. Maxwell CJ, Hogan DB, Ebly EM. Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging. CMAJ 1999;161:501-6.
64. Maxwell CJ, Hogan DB, Campbell NRC, Ebly EM. Nifedipine and mortality risk in the elderly: relevance of drug formulation, dose and duration. Pharmacoepidemiol Drug Saf 2000;9:11-23.
65. Newman SC, Hassan AI. Antidepressant use in the elderly propulation in Canada: results from a national survey. J Gerontol Med Sci 1999;54A:M527-M530.
66. Hogan DB, Maxwell CJ, Fung TS, Ebly EM. Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian Study of Health and Aging. Can J Clin Pharmacol 2003;10:72-7.
67. Egan M, Moride Y, Wolfson C, Monette J. Long-term continuous use of benzodiazepines by older adults in Quebec: prevalence, incidence and risk factors. J Am Geriatr Soc 2000;48:811-6.
68. Rockwood K, Stadnyk K, Macknight C, McDowell I, Hébert R, Hogan DB. A brief clinical instrument to classify frailty in elderly people. Lancet 1999;353:205-6.
69. Hogan DB, Ebly EM, Fung TS. Disease, disability, and age in cognitively intact seniors: results from the Canadian Study of Health and Aging. J Gerontol Med Sci 1999;54A:M77-M82.
70. Hogan DB, Fung TS, Ebly EM. Health, function and survival of a cohort of very old Canadians: Results from the second wave of the Canadian Study of Health and Aging. Can J Public Health 1999;99:338-42.
71. Clarke PJ, Marshall VW, RyffCD, Wheaton B. Measuring psychological well-being in the Canadian Study of Health and Aging. Int Psychogeriatr 2001;13:79-90.
72. Perrault A, Wolfson C, Egan M, Rockwood K, Hogan DB. Prognostic factors for functional independence in older adults with mild dementia: Results from the Canadian Study of Health and Aging. Alzheimer Dis Assoc Disord 2002;16:239-47.
73. O'Rourke N, MacLennan R, Hadjistavropoulos T, Tuokko H. Longitudinal examination of the functional status of older adults: successful aging within a representative Canadian sample. Can J Aging 2000;19:441-55.
74. Mitnitski AB, Graham JE, Mogilner AJ, Rockwood K. Frailty, fitness and late-life mortality in relation to chronological and biological age. BMC Geriatr 2002;2:1-8.
75. Hunskaar S, Østbye T, Borrie MJ. The prevalence of urinary incontinence in elderly Canadians and its association with dementia, ambulatory function, and institutionalization. Norwegian J Epidemiol 1998;8:177-82.
76. Østbye T, Hunskaar S, Sykes E. Predictors and incidence of urinary incontinence in elderly Canadians with and without dementia - a five-year follow up: the Canadian Study of Health and Aging. Can J Aging 2002;21:95-101.